SOMAÍ Pharmaceuticals: Funding, Investors & Team (Sep 2026)
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed at promoting healthy lifestyles through natural medicine. Our focus is on developing a diverse range of cannabis products for chronic conditions, with a goal of providing a seamless experience for patients in administering and purchasing their medication. Operating in Lisbon, Portugal, SOMAÍ Pharmaceuticals is a European biotech company that adheres to EU-GMP standards, ensuring the consistent and effective delivery of cannabinoid pharmaceuticals worldwide. Our emphasis on scientific research and pharmacology allows us to cater to the endocannabinoid system in all markets.
SOMAÍ Pharmaceuticals has raised $4.3M across 1 funding round on record, the most recent a Series B of $4.3M announced in Apr 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SOMAÍ Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2024.
SOMAÍ Pharmaceuticals Funding Rounds
SOMAÍ Pharmaceuticals Founders and Leadership Team
Contact details for the SOMAÍ Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →SOMAÍ Pharmaceuticals Funding Compared to Other Biotechnology Startups
SOMAÍ Pharmaceuticals' latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SOMAÍ Pharmaceuticals in Biotechnology and Dublin
Companies Similar to SOMAÍ Pharmaceuticals
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target…
Impedans furnish you with astute detecting stages for radio-recurrence (RF) and plasma process checking.…
SOMAÍ Pharmaceuticals Funding FAQs
What does SOMAÍ Pharmaceuticals do?
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed at promoting healthy lifestyles through natural medicine. Our focus is on developing a diverse range of cannabis products for chronic conditions, with a goal of providing a seamless experience for patients in administering and purchasing their medication. Operating in Lisbon, Portugal, SOMAÍ Pharmaceuticals is a European biotech company that adheres to EU-GMP standards, ensuring the consistent and effective delivery of cannabinoid pharmaceuticals worldwide. Our emphasis on scientific research and pharmacology allows us to cater to the endocannabinoid system in all markets.
How much funding has SOMAÍ Pharmaceuticals raised?
SOMAÍ Pharmaceuticals has raised $4.3M across 1 round on record. The most recent is a Series B of $4.3M announced in Apr 2024.
When did SOMAÍ Pharmaceuticals last raise funding?
SOMAÍ Pharmaceuticals' most recent funding round on record is a Series B of $4.3M, announced in Apr 2024.
Who founded SOMAÍ Pharmaceuticals?
FundedIQ lists Michael Sassano (Founder) at SOMAÍ Pharmaceuticals.
Where is SOMAÍ Pharmaceuticals headquartered?
SOMAÍ Pharmaceuticals is based in Dublin, Ireland.
How many employees does SOMAÍ Pharmaceuticals have?
SOMAÍ Pharmaceuticals is in the 11-50 employee band.
How does SOMAÍ Pharmaceuticals' funding compare to other Biotechnology startups?
SOMAÍ Pharmaceuticals' latest round of $4.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SOMAÍ Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SOMAÍ Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.